PnPP-19, a Synthetic and Nontoxic Peptide Designed from a Phoneutria nigriventer Toxin, Potentiates Erectile Function via NO/cGMP.
暂无分享,去创建一个
J. Tytgat | J. Cassoli | A. Nunes | L. Felicori | S. Peigneur | C. Chávez-Olórtegui | M. H. Borges | J. Cruz | E. Camargos | C. Castro | J. Resende | F. M. Almeida | M. D. de Lima | M. N. Cordeiro | D. Santos | A. Matavel | K. Nunes | Carolina Nunes da Silva | F. S. Torres | R. A. Machado de Ávila | Arthur Santos-Miranda | S. Lauar | J. M. Resende | Allancer D. C. Nunes
[1] C. Kushmerick,et al. Characteristics of dorsal root ganglia neurons sensitive to Substance P , 2014, Molecular pain.
[2] Z. Ye,et al. saRNA guided iNOS up-regulation improves erectile function of diabetic rats. , 2013, The Journal of urology.
[3] C. Vlachopoulos,et al. Erectile dysfunction in the cardiovascular patient. , 2013, European heart journal.
[4] M. H. Borges,et al. New insights on arthropod toxins that potentiate erectile function. , 2013, Toxicon : official journal of the International Society on Toxinology.
[5] F. Montorsi,et al. Erectile dysfunction as a cardiovascular risk factor in patients with diabetes , 2013, Endocrine.
[6] M. Srougi,et al. Phoneutria nigriventer spider toxin Tx2-6 causes priapism and death: a histopathological investigation in mice. , 2012, Toxicon : official journal of the International Society on Toxinology.
[7] R. Webb,et al. Increased cavernosal relaxation by Phoneutria nigriventer toxin, PnTx2-6, via activation at NO/cGMP signaling , 2011, International Journal of Impotence Research.
[8] K. Andersson. Mechanisms of Penile Erection and Basis for Pharmacological Treatment of Erectile Dysfunction , 2011, Pharmacological Reviews.
[9] A. V. Santos,et al. Functional expression of a recombinant toxin - rPnTx2-6 - active in erectile function in rat. , 2010, Toxicon : official journal of the International Society on Toxinology.
[10] V. Cardoso,et al. Nitric oxide-induced vasorelaxation in response to PnTx2-6 toxin from Phoneutria nigriventer spider in rat cavernosal tissue. , 2010, The journal of sexual medicine.
[11] J. Heidelbaugh. Management of erectile dysfunction. , 2010, American family physician.
[12] C. Stief,et al. Anatomy, physiology, and pathophysiology of erectile dysfunction. , 2010, The journal of sexual medicine.
[13] D. Kouvelas,et al. PDE5 inhibitors: in vitro and in vivo pharmacological profile. , 2009, Current pharmaceutical design.
[14] F. Molina,et al. Structure and activity analysis of two spider toxins that alter sodium channel inactivation kinetics. , 2009, Biochemistry.
[15] B. Arnould,et al. Improvement in quality of sexual life in female partners of men with erectile dysfunction treated with sildenafil citrate: findings of the Index of Sexual Life (ISL) in a couple study. , 2009, The journal of sexual medicine.
[16] V. Bovbjerg,et al. Sexual functioning of Latino women seeking outpatient gynecologic care. , 2009, The journal of sexual medicine.
[17] M. Srougi,et al. Penile erection induced in vivo by a purified toxin from the Brazilian spider Phoneutria nigriventer , 2008, BJU international.
[18] D. Hirst,et al. Gene therapy via inducible nitric oxide synthase: a tool for the treatment of a diverse range of pathological conditions , 2008, The Journal of pharmacy and pharmacology.
[19] R. Webb,et al. Tx2-6 toxin of the Phoneutria nigriventer spider potentiates rat erectile function. , 2008, Toxicon : official journal of the International Society on Toxinology.
[20] L. Derogatis,et al. The epidemiology of sexual dysfunctions. , 2008, The journal of sexual medicine.
[21] T. Shioya. A simple technique for isolating healthy heart cells from mouse models. , 2007, The journal of physiological sciences : JPS.
[22] M. Litwin,et al. Health-related quality of life in men with erectile dysfunction , 1998, Journal of General Internal Medicine.
[23] A. Hajrasouliha,et al. Effect of anandamide on nonadrenergic noncholinergic-mediated relaxation of rat corpus cavernosum. , 2006, European journal of pharmacology.
[24] A. Burnett,et al. RhoA/Rho-kinase in erectile tissue: mechanisms of disease and therapeutic insights. , 2006, Clinical science.
[25] T. Lue,et al. Physiology of penile erection and pathophysiology of erectile dysfunction. , 2005, The Urologic clinics of North America.
[26] N. Toda,et al. Nitric oxide and penile erectile function. , 2005, Pharmacology & therapeutics.
[27] A. Jungwirth. [Physiology and pathophysiology of erectile dysfunction]. , 2000, Wiener medizinische Wochenschrift.
[28] Aytaç,et al. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences , 1999, BJU international.
[29] S. Kaul,et al. Writing Group Members , 2022 .
[30] S. Kaul,et al. ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/American Heart Association. , 1999, Journal of the American College of Cardiology.
[31] J. Tytgat,et al. Subunit stoichiometry of a mammalian K+ channel determined by construction of multimeric cDNAs , 1992, Neuron.